(Q44120839)

English

Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot study

scientific article published in August 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Wildemeersch D

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Schacht E

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Wildemeersch P

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

93-99

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

The normal menopause transition

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Menstrual Blood Loss–A Population Study: Variation at different ages and attempts to define normality

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Unintended Pregnancy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

A risk-benefit assessment of the levonorgestrel-releasing intrauterine system

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Endometrial suppression with a new 'frameless' levonorgestrel releasing intrauterine system in perimenopausal and postmenopausal women: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Contraception with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Recommended Procedures for the Statistical Evaluation of Intrauterine Contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Life-table methods for contraceptive research

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Intrauterine device and upper-genital-tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Risk of clinical pelvic inflammatory disease attributable to an intrauterine device

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Intra-uterine contraception and the risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Intrauterine administration of levonorgestrel in two low doses in HRT. A randomized clinical trial during one year: effects on lipid and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

The hormonal situation in the perimenopausal period

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900324-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0010-7824(02)00324-4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44120839&oldid=2106794530"